Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$6.53 USD
+0.49 (8.11%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.52 -0.01 (-0.15%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Tango Therapeutics, Inc. has a market cap of $654.70M, which represents its share price of $6.04 multiplied by its outstanding shares number of 108.39M. As a small-cap company, TNGX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TNGX 6.53 +0.49(8.11%)
Will TNGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TNGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNGX
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
TNGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Tango Therapeutics (TNGX) Could Rally 61.46%: Here's is How to Trade
Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect?
Other News for TNGX
Tango Therapeutics management to meet with Cantor Fitzgerald
Tango Therapeutics management to meet with Cantor Fitzgerald
Tango Therapeutics management to meet with Cantor Fitzgerald
TNGX: Upcoming Meetings in San Francisco and Denver
Tango Therapeutics management to meet with Cantor Fitzgerald